These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 26084553)

  • 21. DLJ14, a novel chemo-sensitization agent, enhances therapeutic effects of adriamycin against MCF-7/A cells both in vitro and in vivo.
    Zhang P; Zheng BB; Wang HY; Chen JH; Liu XY; Guo XL
    J Pharm Pharmacol; 2014 Mar; 66(3):398-407. PubMed ID: 24533823
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adenovirus-mediated p53 gene therapy reverses resistance of breast cancer cells to adriamycin.
    Qi X; Chang Z; Song J; Gao G; Shen Z
    Anticancer Drugs; 2011 Jul; 22(6):556-62. PubMed ID: 21637162
    [TBL] [Abstract][Full Text] [Related]  

  • 23. P-glycoprotein antagonists confer synergistic sensitivity to short-chain ceramide in human multidrug-resistant cancer cells.
    Chapman JV; Gouazé-Andersson V; Karimi R; Messner MC; Cabot MC
    Exp Cell Res; 2011 Jul; 317(12):1736-45. PubMed ID: 21396934
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Doxorubicin loaded pH-sensitive polymeric micelles for reversal of resistant MCF-7 tumor.
    Lee ES; Na K; Bae YH
    J Control Release; 2005 Mar; 103(2):405-18. PubMed ID: 15763623
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Co-delivery of Doxorubicin and Ceramide in a Liposomal Formulation Enhances Cytotoxicity in Murine B16BL6 Melanoma Cell Lines.
    Chen L; Alrbyawi H; Poudel I; Arnold RD; Babu RJ
    AAPS PharmSciTech; 2019 Feb; 20(3):99. PubMed ID: 30719596
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Possible role of ceramide as an indicator of chemoresistance: decrease of the ceramide content via activation of glucosylceramide synthase and sphingomyelin synthase in chemoresistant leukemia.
    Itoh M; Kitano T; Watanabe M; Kondo T; Yabu T; Taguchi Y; Iwai K; Tashima M; Uchiyama T; Okazaki T
    Clin Cancer Res; 2003 Jan; 9(1):415-23. PubMed ID: 12538495
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polyethylene glycol-conjugated hyaluronic acid-ceramide self-assembled nanoparticles for targeted delivery of doxorubicin.
    Cho HJ; Yoon IS; Yoon HY; Koo H; Jin YJ; Ko SH; Shim JS; Kim K; Kwon IC; Kim DD
    Biomaterials; 2012 Feb; 33(4):1190-200. PubMed ID: 22074664
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mixed backbone antisense glucosylceramide synthase oligonucleotide (MBO-asGCS) loaded solid lipid nanoparticles: in vitro characterization and reversal of multidrug resistance in NCI/ADR-RES cells.
    Siddiqui A; Patwardhan GA; Liu YY; Nazzal S
    Int J Pharm; 2010 Nov; 400(1-2):251-9. PubMed ID: 20816930
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhanced antitumor and anti-metastasis efficiency via combined treatment with CXCR4 antagonist and liposomal doxorubicin.
    Mei L; Liu Y; Zhang Q; Gao H; Zhang Z; He Q
    J Control Release; 2014 Dec; 196():324-31. PubMed ID: 25450404
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ROS-triggered and regenerating anticancer nanosystem: an effective strategy to subdue tumor's multidrug resistance.
    Su Z; Chen M; Xiao Y; Sun M; Zong L; Asghar S; Dong M; Li H; Ping Q; Zhang C
    J Control Release; 2014 Dec; 196():370-83. PubMed ID: 25278256
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glucosylceramide synthase blockade down-regulates P-glycoprotein and resensitizes multidrug-resistant breast cancer cells to anticancer drugs.
    Gouazé V; Liu YY; Prickett CS; Yu JY; Giuliano AE; Cabot MC
    Cancer Res; 2005 May; 65(9):3861-7. PubMed ID: 15867385
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Down-regulation of c-fos by shRNA sensitizes adriamycin-resistant MCF-7/ADR cells to chemotherapeutic agents via P-glycoprotein inhibition and apoptosis augmentation.
    Shi R; Peng H; Yuan X; Zhang X; Zhang Y; Fan D; Liu X; Xiong D
    J Cell Biochem; 2013 Aug; 114(8):1890-900. PubMed ID: 23494858
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhanced antitumor activity of different double arms polyethyleneglycol-modified liposomal doxorubicin.
    Sugiyama I; Sadzuka Y
    Int J Pharm; 2013 Jan; 441(1-2):279-84. PubMed ID: 23194885
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overcoming cellular multidrug resistance using classical nanomedicine formulations.
    Kunjachan S; Błauż A; Möckel D; Theek B; Kiessling F; Etrych T; Ulbrich K; van Bloois L; Storm G; Bartosz G; Rychlik B; Lammers T
    Eur J Pharm Sci; 2012 Mar; 45(4):421-8. PubMed ID: 21907796
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Physicochemical and biological characterization of ceramide-containing liposomes: paving the way to ceramide therapeutic application.
    Khazanov E; Priev A; Shillemans JP; Barenholz Y
    Langmuir; 2008 Jun; 24(13):6965-80. PubMed ID: 18512883
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhanced gene delivery efficiency of cationic liposomes coated with PEGylated hyaluronic acid for anti P-glycoprotein siRNA: a potential candidate for overcoming multi-drug resistance.
    Ran R; Liu Y; Gao H; Kuang Q; Zhang Q; Tang J; Huang K; Chen X; Zhang Z; He Q
    Int J Pharm; 2014 Dec; 477(1-2):590-600. PubMed ID: 25448564
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Suppression in mice of immunosurveillance against PEGylated liposomes by encapsulated doxorubicin.
    Yahuafai J; Asai T; Nakamura G; Fukuta T; Siripong P; Hyodo K; Ishihara H; Kikuchi H; Oku N
    J Control Release; 2014 Oct; 192():167-73. PubMed ID: 25041998
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulation of multidrug resistance gene expression in human breast cancer cells by (-)-gossypol-enriched cottonseed oil.
    Ye W; Chang HL; Wang LS; Huang YW; Shu S; Dowd MK; Wan PJ; Sugimoto Y; Lin YC
    Anticancer Res; 2007; 27(1A):107-16. PubMed ID: 17352222
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of glucosylceramide synthase, converting ceramide to glucosylceramide, confers adriamycin resistance in human breast cancer cells.
    Liu YY; Han TY; Giuliano AE; Cabot MC
    J Biol Chem; 1999 Jan; 274(2):1140-6. PubMed ID: 9873062
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anticancer activity of PEGylated matrix metalloproteinase cleavable peptide-conjugated adriamycin against malignant glioma cells.
    Lim SH; Jeong YI; Moon KS; Ryu HH; Jin YH; Jin SG; Jung TY; Kim IY; Kang SS; Jung S
    Int J Pharm; 2010 Mar; 387(1-2):209-14. PubMed ID: 19945519
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.